Page last updated: 2024-12-08

royleanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

royleanone: from root of Salvia officinalis; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
SalviagenusA genus in the mint family (LAMIACEAE).[MeSH]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]

Cross-References

ID SourceID
PubMed CID442084
CHEMBL ID1813341
CHEBI ID8904
SCHEMBL ID21291506
MeSH IDM0270359

Synonyms (25)

Synonym
nsc-122417
royleanone
C09182
6812-87-9
AC1L9C85 ,
AKOS004901865 ,
chebi:8904 ,
CHEMBL1813341 ,
nsc753735
nsc-753735
1377-96-4
901618Q8AX ,
1,4-phenanthrenedione, 4b,5,6,7,8,8a,9,10-octahydro-3-hydroxy-4b,8,8-trimethyl-2-(1-methylethyl)-, (4bs,8as)-
podocarpa-8,12-diene-11,14-dione, 12-hydroxy-13-isopropyl-
1,4-phenanthrenedione, 4b,5,6,7,8,8a,9,10-octahydro-3-hydroxy-4b,8,8-trimethyl-2-(1-methylethyl)-, (4bs-trans)-
12-hydroxy-8,12-abietadiene-11,14-dione
unii-901618q8ax
(4bs,8as)-3-hydroxy-2-isopropyl-4b,8,8-trimethyl- 4b,5,6,7,8,8a,9,10-octahydrophenanthrene-1,4-dione
AKOS032948936
FS-8601
Q27108179
SCHEMBL21291506
(+)-royleanone
CS-0016746
HY-N1338
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID1058382Cytotoxicity against human MRC5 cells assessed as growth inhibition by WST-8 assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Cytotoxic compounds from invasive giant salvinia (Salvinia molesta) against human tumor cells.
AID1058386Cytotoxicity against human HL60 cells assessed as growth inhibition by WST-8 assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Cytotoxic compounds from invasive giant salvinia (Salvinia molesta) against human tumor cells.
AID769609Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Antiproliferative activity of abietane diterpenoids against human tumor cells.
AID1058388Cytotoxicity against human A549 cells assessed as growth inhibition by WST-8 assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Cytotoxic compounds from invasive giant salvinia (Salvinia molesta) against human tumor cells.
AID769611Cytotoxicity against human U937 cells after 72 hrs by MTT assay2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Antiproliferative activity of abietane diterpenoids against human tumor cells.
AID1058385Cytotoxicity against human PANC1 cells assessed as growth inhibition by WST-8 assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Cytotoxic compounds from invasive giant salvinia (Salvinia molesta) against human tumor cells.
AID769610Cytotoxicity against human MOLT3 cells after 72 hrs by MTT assay2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Antiproliferative activity of abietane diterpenoids against human tumor cells.
AID1058384Cytotoxicity against human BxPC3 cells assessed as growth inhibition by WST-8 assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Cytotoxic compounds from invasive giant salvinia (Salvinia molesta) against human tumor cells.
AID612372Cytotoxicity against human MV-3 cells after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Aug-15, Volume: 19, Issue:16
In vitro cytotoxic activity of abietane diterpenes from Peltodon longipes as well as Salvia miltiorrhiza and Salvia sahendica.
AID1304621Antileishmanial activity against Leishmania donovani LV82 promastigotes expressing red fluorescent protein after 72 hrs by flow cytometric analysis2016Journal of natural products, Mar-25, Volume: 79, Issue:3
Antileishmanial and Cytotoxic Activity of Some Highly Oxidized Abietane Diterpenoids from the Bald Cypress, Taxodium distichum.
AID1058387Cytotoxicity against human PC3 cells assessed as growth inhibition by WST-8 assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Cytotoxic compounds from invasive giant salvinia (Salvinia molesta) against human tumor cells.
AID1304623Antileishmanial activity against transgenic Leishmania amazonensis amastigotes infected in CD-1 mouse peritoneal macrophages assessed as beta-lactamase activity after 72 hrs by nitrocefin dye-based spectrophotometric analysis2016Journal of natural products, Mar-25, Volume: 79, Issue:3
Antileishmanial and Cytotoxic Activity of Some Highly Oxidized Abietane Diterpenoids from the Bald Cypress, Taxodium distichum.
AID612371Cytotoxicity against human MIAPaCa2 cells after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Aug-15, Volume: 19, Issue:16
In vitro cytotoxic activity of abietane diterpenes from Peltodon longipes as well as Salvia miltiorrhiza and Salvia sahendica.
AID769612Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Antiproliferative activity of abietane diterpenoids against human tumor cells.
AID769608Cytotoxicity against human SK-MEL-1 cells after 72 hrs by MTT assay2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Antiproliferative activity of abietane diterpenoids against human tumor cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (5.88)18.2507
2000's4 (23.53)29.6817
2010's10 (58.82)24.3611
2020's2 (11.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]